Product NDC: | 52584-021 |
Proprietary Name: | Isuprel |
Non Proprietary Name: | Isuprel |
Active Ingredient(s): | .2 mg/mL & nbsp; Isuprel |
Administration Route(s): | INTRACARDIAC; INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 52584-021 |
Labeler Name: | General Injectables & Vaccines, Inc |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA010515 |
Marketing Category: | NDA |
Start Marketing Date: | 20100301 |
Package NDC: | 52584-021-01 |
Package Description: | 1 AMPULE in 1 BAG (52584-021-01) > 1 mL in 1 AMPULE |
NDC Code | 52584-021-01 |
Proprietary Name | Isuprel |
Package Description | 1 AMPULE in 1 BAG (52584-021-01) > 1 mL in 1 AMPULE |
Product NDC | 52584-021 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Isuprel |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRACARDIAC; INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS |
Start Marketing Date | 20100301 |
Marketing Category Name | NDA |
Labeler Name | General Injectables & Vaccines, Inc |
Substance Name | ISOPROTERENOL HYDROCHLORIDE |
Strength Number | .2 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Adrenergic beta-Agonists [MoA],beta-Adrenergic Agonist [EPC] |